Skip to main content
Top
Published in: BMC Endocrine Disorders 1/2021

Open Access 01-12-2021 | Erectile Dysfunction | Research

Erectile dysfunction and associated factors among diabetic patients at, Hawassa, Southern, Ethiopia

Authors: Maradona Zeleke, Dejene Hailu, Deresse Daka

Published in: BMC Endocrine Disorders | Issue 1/2021

Login to get access

Abstract

Background

Erectile dysfunction is an inability to initiate and have a persistent erection firm enough to have satisfying sexual intercourse. The prevalence of erectile dysfunction in diabetic men is considerably high, but it is often underdiagnosed and under-managed.

Objective

This study aimed to determine erectile dysfunction and associated factors among diabetic patients at, Hawassa, Southern, Ethiopia.

Methods

The institution-based cross-sectional study was conducted on 352 adult male diabetic patients randomly selected from Adare general and Hawassa comprehensive specialized hospitals using a simple random sampling technique. The number of patients to be selected from each hospital was proportionally assigned based on the total population of diabetes mellitus patients following chronic care during the study period. The descriptive statistics and multiple logistic regressions (bivariate and multivariate analysis) were carried out.

Result

The prevalence of erectile dysfunction was 72.2% (95%CI, 1.76–3.68). After adjusting all factors, old age, diabetes duration, drinking alcohol, and poor glycemic control had shown significant association with erectile dysfunction.

Conclusion

The occurrence of erectile dysfunction in this study community is very high. Drinking alcohol, poor glycemic control, age, and duration of diabetes were predictors of erectile dysfunction in this study area. Assessment and management of erectile dysfunction in the diabetic clinic should be part of routine medical care during follow-up visits with diabetic patients. Healthcare providers should emphasize screening and treating older patients and those who have had a diabetes diagnosis for a longer duration.
Appendix
Available only for authorised users
Literature
2.
go back to reference Abay M. Prevalence and determinants of erectile dysfunction among diabetic patients attending in hospitals of central and northwestern zone of Tigray. BMC Endocrine Disord BMC. 2017;17(16). Abay M. Prevalence and determinants of erectile dysfunction among diabetic patients attending in hospitals of central and northwestern zone of Tigray. BMC Endocrine Disord BMC. 2017;17(16).
4.
go back to reference Shiferaw WS, Akalu TY, Aynalem YA. Prevalence of erectile dysfunction in patients with diabetes mellitus and its association with body mass index and glycated hemoglobin in africa: a systematic review and meta-analysis. Int J Endocrinol. 2020;2020. Shiferaw WS, Akalu TY, Aynalem YA. Prevalence of erectile dysfunction in patients with diabetes mellitus and its association with body mass index and glycated hemoglobin in africa: a systematic review and meta-analysis. Int J Endocrinol. 2020;2020.
6.
go back to reference Mohamed AH, Yaseen K, Ranjeev H. Assessment of knowledge and perception of erectile dysfunction among diabetic and non-diabetic patients at a university health center in Malaysia. Asian J Pharmaceut Clin Res. 2009;2(3). Mohamed AH, Yaseen K, Ranjeev H. Assessment of knowledge and perception of erectile dysfunction among diabetic and non-diabetic patients at a university health center in Malaysia. Asian J Pharmaceut Clin Res. 2009;2(3).
7.
go back to reference Penson DF, Wessells H. Erectile Dysfunction in Diabetic Patients. Diabetes Spectrum. 2004;17(4):225-30. Penson DF, Wessells H. Erectile Dysfunction in Diabetic Patients. Diabetes Spectrum. 2004;17(4):225-30.
11.
go back to reference Singh K, Devi S, Pankaj PP. Diabetes associated male reproductive dysfunctions: prevalence, diagnosis and risk factors. Int J Drug Dev and Res. 2016;8(2):007–10. Singh K, Devi S, Pankaj PP. Diabetes associated male reproductive dysfunctions: prevalence, diagnosis and risk factors. Int J Drug Dev and Res. 2016;8(2):007–10.
12.
go back to reference Van Vo T, Hoang HD, Thanh Nguyen NP. Prevalence and associated factors of erectile dysfunction among married men in Vietnam. Front Public Health. 2017;5:94.CrossRef Van Vo T, Hoang HD, Thanh Nguyen NP. Prevalence and associated factors of erectile dysfunction among married men in Vietnam. Front Public Health. 2017;5:94.CrossRef
14.
go back to reference Sharifi F, Asghari M, Jaberi Y, Salehi O, Mirzamohammadi F. Independent predictors of erectile dysfunction in type 2 diabetes mellitus: is it true what they say about risk factors? ISRN Endocrinol. 2012;2012(5). Sharifi F, Asghari M, Jaberi Y, Salehi O, Mirzamohammadi F. Independent predictors of erectile dysfunction in type 2 diabetes mellitus: is it true what they say about risk factors? ISRN Endocrinol. 2012;2012(5).
15.
go back to reference Ugwu T, Ezeani I, Onung S, Kolawole B, Ikem R. Predictors of erectile dysfunction in men with type 2 diabetes mellitus referred to a tertiary healthcare centre. Adv Endocrinol. 2016;2016(8). Ugwu T, Ezeani I, Onung S, Kolawole B, Ikem R. Predictors of erectile dysfunction in men with type 2 diabetes mellitus referred to a tertiary healthcare centre. Adv Endocrinol. 2016;2016(8).
16.
go back to reference Baldé NM, Diallo AB, Baldé MC, et al. Dysfonction érectile et diabète à Conakry (Guin’ee): fréquence et profil clinique à partir de 187 observations. Ann Endocrinol. 2006;67(4):338–42.CrossRef Baldé NM, Diallo AB, Baldé MC, et al. Dysfonction érectile et diabète à Conakry (Guin’ee): fréquence et profil clinique à partir de 187 observations. Ann Endocrinol. 2006;67(4):338–42.CrossRef
17.
go back to reference El Saghier EOA, Shebl SE, Fawzy OA, Eltayeb LM, Bekhet LM, Gharib A. Androgen deficiency and erectile dysfunction in patients with type 2 diabetes. Clin Med Insights: Endocrinol Diabetes. 2015;8:S27700. El Saghier EOA, Shebl SE, Fawzy OA, Eltayeb LM, Bekhet LM, Gharib A. Androgen deficiency and erectile dysfunction in patients with type 2 diabetes. Clin Med Insights: Endocrinol Diabetes. 2015;8:S27700.
18.
go back to reference Kemp T, Rheeder P. Prevalence and associations of erectile dysfunction in a south African male diabetic urban population journal of endocrinology. Metabol Diabetes South Afr. 2015;20(3):134–9. Kemp T, Rheeder P. Prevalence and associations of erectile dysfunction in a south African male diabetic urban population journal of endocrinology. Metabol Diabetes South Afr. 2015;20(3):134–9.
20.
go back to reference Lokrou A, Soumahoro SI. La dysfonction érectile chez les personnes atteintes de diabète en Côte-d’Ivoire. Médecine des Maladies Métaboliques. 2011;5(2):203–7.CrossRef Lokrou A, Soumahoro SI. La dysfonction érectile chez les personnes atteintes de diabète en Côte-d’Ivoire. Médecine des Maladies Métaboliques. 2011;5(2):203–7.CrossRef
21.
go back to reference Olarinoye J, Kuranga S, Katibi I, Adediran O, Jimoh A, Sanya E. Prevalence and determinants of erectile dysfunction among people with type 2 diabetes in Ilorin, Nigeria. Niger Postgrad Med J. 2006;13(4):291–6.PubMed Olarinoye J, Kuranga S, Katibi I, Adediran O, Jimoh A, Sanya E. Prevalence and determinants of erectile dysfunction among people with type 2 diabetes in Ilorin, Nigeria. Niger Postgrad Med J. 2006;13(4):291–6.PubMed
24.
go back to reference Adisu BW, Sewnet AK, Biruk ST. Prevalence of erectile dysfunction and its associated factors among patients with diabetes in Ethiopia: a systematic review and meta-analysis. J Int Med Res. 2021;49(2):1–10. Adisu BW, Sewnet AK, Biruk ST. Prevalence of erectile dysfunction and its associated factors among patients with diabetes in Ethiopia: a systematic review and meta-analysis. J Int Med Res. 2021;49(2):1–10.
28.
go back to reference Asefa A, Nigussie T, Henok A, et al. Prevalence of sexual dysfunction and related factors among diabetes mellitus patients in Southwest Ethiopia. BMC Endocr Disord. 2019;19(141). Asefa A, Nigussie T, Henok A, et al. Prevalence of sexual dysfunction and related factors among diabetes mellitus patients in Southwest Ethiopia. BMC Endocr Disord. 2019;19(141).
31.
go back to reference Selim S, Chowdhury SH, Azad AK, Chowdhury MAJ, Rahaman FR. Frequency and risk factors of erectile dysfunction in Bangladeshi diabetic men. J Endocrinol Diabetes Obes. 2015;3(3):1075. Selim S, Chowdhury SH, Azad AK, Chowdhury MAJ, Rahaman FR. Frequency and risk factors of erectile dysfunction in Bangladeshi diabetic men. J Endocrinol Diabetes Obes. 2015;3(3):1075.
32.
go back to reference Unadike BC, Eregie A, Ohwovoviole AE. Prevalence and types of sexual dysfunction amongst males with diabetes in Nigeria. Afr J Diabetes Med. 2008;2008:18–20. Unadike BC, Eregie A, Ohwovoviole AE. Prevalence and types of sexual dysfunction amongst males with diabetes in Nigeria. Afr J Diabetes Med. 2008;2008:18–20.
34.
36.
go back to reference Khatib FA, Jarrah NS, Shegem NS, Bateiha AM, Abu-Ali RM, Ajlouni KM. Sexual dysfunction among Jordanian men with diabetes. Saudi Med J. 2006;27(3):351–6.PubMed Khatib FA, Jarrah NS, Shegem NS, Bateiha AM, Abu-Ali RM, Ajlouni KM. Sexual dysfunction among Jordanian men with diabetes. Saudi Med J. 2006;27(3):351–6.PubMed
37.
go back to reference Culley C, Roger S, Irwin G, Michael G. Textbook of erectile dysfunction; 2009. Culley C, Roger S, Irwin G, Michael G. Textbook of erectile dysfunction; 2009.
38.
go back to reference Rosen RC, Cappelleri JC, Smith MD, Lipsky J, Peña BM. Development and evaluation of an abridged, 5-item version of the International Index of Erectile Function (IIEF-5) as a diagnostic tool for erectile dysfunction. Int J Impot Res. 1999;11(6):319-26. https://doi.org/10.1038/sj.ijir.3900472. Rosen RC, Cappelleri JC, Smith MD, Lipsky J, Peña BM. Development and evaluation of an abridged, 5-item version of the International Index of Erectile Function (IIEF-5) as a diagnostic tool for erectile dysfunction. Int J Impot Res. 1999;11(6):319-26. https://​doi.​org/​10.​1038/​sj.​ijir.​3900472.
39.
go back to reference Mohamed AK, Sonbol A. Study of risk factors for erectile dysfunction in patients with type 2 diabetes mellitus: correlation to serum testosterone level. Elsevier, Alexandria J Med. 2018;54:319–21.CrossRef Mohamed AK, Sonbol A. Study of risk factors for erectile dysfunction in patients with type 2 diabetes mellitus: correlation to serum testosterone level. Elsevier, Alexandria J Med. 2018;54:319–21.CrossRef
41.
go back to reference Martin-Morales A, Sanchez-Cruz JJ, Saenz de Tejada I, et al. Prevalence and independent risk factors for erectile dysfunction in Spain: results of the Epidemiologia de la Disfuncion Erectil Masculina Study. J Urol. 2001;166(2):569–74.CrossRef Martin-Morales A, Sanchez-Cruz JJ, Saenz de Tejada I, et al. Prevalence and independent risk factors for erectile dysfunction in Spain: results of the Epidemiologia de la Disfuncion Erectil Masculina Study. J Urol. 2001;166(2):569–74.CrossRef
43.
go back to reference Cho NH, Ahn CW, Park JY, Ahn TY, Lee HW, Park TS, et al. Prevalence of erectile dysfunction in Korean men with type 2 diabetes mellitus. Diabet Med. 2005;23:198–203.CrossRef Cho NH, Ahn CW, Park JY, Ahn TY, Lee HW, Park TS, et al. Prevalence of erectile dysfunction in Korean men with type 2 diabetes mellitus. Diabet Med. 2005;23:198–203.CrossRef
45.
go back to reference Owiredu KBA, et al. Determinants of sexual dysfunction among clinically diagnosed diabetic patients. Reprod Biol Endocrinol. 2011;9(70). Owiredu KBA, et al. Determinants of sexual dysfunction among clinically diagnosed diabetic patients. Reprod Biol Endocrinol. 2011;9(70).
Metadata
Title
Erectile dysfunction and associated factors among diabetic patients at, Hawassa, Southern, Ethiopia
Authors
Maradona Zeleke
Dejene Hailu
Deresse Daka
Publication date
01-12-2021
Publisher
BioMed Central
Published in
BMC Endocrine Disorders / Issue 1/2021
Electronic ISSN: 1472-6823
DOI
https://doi.org/10.1186/s12902-021-00807-5

Other articles of this Issue 1/2021

BMC Endocrine Disorders 1/2021 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.